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NADPH oxidases (NOXs) are the only enzymes exclusively dedicated
to reactive oxygen species (ROS) generation. Dysregulation of these
polytopic membrane proteins impacts the redox signaling cascades
that control cell proliferation and death. We describe the atomic
crystal structures of the catalytic flavin adenine dinucleotide (FAD)-
and heme-binding domains of Cylindrospermum stagnale NOX5.
The two domains form the core subunit that is common to all seven
members of the NOX family. The domain structures were then
docked in silico to provide a generic model for the NOX family. A
linear arrangement of cofactors (NADPH, FAD, and two membrane-
embedded heme moieties) injects electrons from the intracellular
side across the membrane to a specific oxygen-binding cavity on
the extracytoplasmic side. The overall spatial organization of critical
interactions is revealed between the intracellular loops on the trans-
membrane domain and the NADPH-oxidizing dehydrogenase do-
main. In particular, the C terminus functions as a toggle switch,
which affects access of the NADPH substrate to the enzyme. The
essence of this mechanistic model is that the regulatory cues con-
formationally gate NADPH-binding, implicitly providing a handle for
activating/deactivating the very first step in the redox chain. Such
insight provides a framework to the discovery of much needed
drugs that selectively target the distinct members of the NOX family
and interfere with ROS signaling.
membrane protein | reactive oxygen species | oxidative stress |
redox biology | NOX
The NADPH-oxidases (NOXs) form the only known enzymefamily whose sole function is reactive oxygen species (ROS)
generation (1, 2). Initially described in mammalian phagocytes
and called phagocyte oxidases, NOXs were shown to function as
“bacterial killers” through the production of bactericidal oxygen
species using molecular oxygen and NADPH as substrates. The
importance of the phagocyte oxidase (now known as NOX2) in
host defense was demonstrated by the severe infections that occur
in patients affected by chronic granulomatous disease, in which the
phagocytes suffer by inefficient superoxide-producing NOX ac-
tivities (3). After this initial discovery, it was found that mammals
contain several enzyme isoforms: NOX1–5 and Duox1–2, which
differ with respect to their specific activities and tissue distribution
(2). Each of these seven human NOXs is finely regulated by
protein–protein interactions and signaling molecules to be acti-
vated only after the proper physiological stimuli. Consistently,
NOXs are typically associated to cytosolic protein partners, which
can switch on/off the oxidase activity. It has now become clear that
NOXs primarily function as key players in cell differentiation,
senescence, and apoptosis (4–8). Of note, oncogene expression has
been widely reported to depend upon ROS production to exert its
mitogenic effects and NOX1/4 are emerging as attractive targets
for anticancer chemo-therapeutics (9–11). Pharmacological in-
tervention on NOXs, which is intensively sought against in-
flammatory and oncology diseases, is currently hampered by the
lack of selective drugs (12).
NOXs are membrane proteins that share the same catalytic
core: a six transmembrane helical domain (TM) and a C-terminal
cytosolic dehydrogenase domain (DH). DH contains the binding
sites for FAD (flavin adenine dinucleotide) and NADPH, whereas
TM binds two hemes (1, 2, 13). The enzyme catalytic cycle entails
a series of steps, which sequentially transfer electrons from cyto-
solic NADPH to an oxygen-reducing center located on the
extracytoplasmic side of the membrane (hereafter referred to as
the “outer side”). Thus, a distinctive feature of NOXs is that
NADPH oxidation and ROS production take place on the op-
posite sides of the membrane (1, 2). The main obstacle to the
structural and mechanistic investigation of NOX’s catalysis and
regulation has been the difficulty encountered with obtaining well-
behaved proteins in sufficient amounts. In fact, the overexpression
of NOXs is often toxic to cells, with consequent loss of biomass
and final protein yield. Moreover, upon extraction from the
membranes, these enzymes tend to proteolyze spontaneously and
lose their noncovalently bound cofactors (FAD and hemes).
Therefore, a different approach had to be devised to achieve a
crystallizable protein. We reasoned that the single-subunit NOX5
could be an attractive system for structural studies because it does
not require accessory proteins for its function, which is instead
regulated by an N-terminal calcium-binding EF-hand domain (Fig.
S1A) (14, 15). Several eukaryotic and prokaryotic NOX5 orthologs
were investigated for recombinant protein expression and stability.
We found Cylindrospermum stagnale NOX5 (csNOX5) to be
promising for structural studies. csNOX5 bears a very significant
40% sequence identity to human NOX5 and was likely acquired
by cyanobacteria through gene transfer from a higher eukaryote
(Fig. S1B) (14). To overcome proteolysis issues presented by
the full-length csNOX5, we adopted a “divide and conquer” ap-
proach and proceeded to work on the individual domains. Here,
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we describe crystal structures of DH and TM, forming the catalytic
core common to the whole NOX family. We also describe a
mutation of the cytosolic DH that drastically increases its stability
in solution and was key to crystallize it. The structural analysis,
supported by kinetics and mutagenesis data, presented herein,
reveals in unprecedented detail the mechanisms of electron
transfer and dioxygen reduction. This structural model consider-
ably advances our understanding of the conformational changes
and molecular interactions that orchestrate NOX regulation.
Results and Discussion
A Hyperstabilizing Mutation Enabled the Structural Elucidation of
NOX’s DH Domain. Purified recombinant C. stagnale DH (residues
413–693; csDH) did not retain the FAD cofactor, possibly a
symptom of poor protein stability, and crystals did not grow in any
of the tested conditions. However, in the course of the pro-
tein expression screenings, we serendipitously found that addition
of the amino acid sequence PWLELAAA after the C-terminal
Phe693 generated a mutant csDH with dramatically enhanced
thermal stability (19 °C increase in the unfolding temperature) and
FAD retention (Fig. 1A). The C-terminal residues are highly
conserved (Fig. S1B), and the described extension may represent a
generally effective way to increase the stability of other NOX
enzymes. Crystals of mutant csDH were obtained in vapor-
diffusion experiments and the structure solved at 2.2-Å resolu-
tion (Table S1). The Trp of the added PW695LELAAA positions
itself in front of the isoalloxazine ring of FAD with a face-to-face
π-stacking interaction (Fig. 1B and Fig. S1 C and D). This Trp–
FAD interaction hinders access of the nicotinamide ring of
NADP+ to its binding pocket. However, we found that the mu-
tated csDH effectively oxidizes NADPH, albeit with a fivefold
slower rate compared with the WT (Fig. 1C and Table S2). This
observation indicates that the C-terminally added PW695LELAAA
residues might locally change conformation to allow NADPH-
binding. Indeed, in silico docking shows that upon displacement
of Trp695, NADPH can easily be modeled to fit in the crevice at
the interface of the NADPH- and FAD-binding lobes of DH with
the same binding mode observed across the ferredoxin-NADPH
reductase superfamily (Fig. 1D) (16). On this basis, it can be
concluded that our csDH mutant is most likely stabilized in an
active conformation, which simply requires the displacement of
the C-terminally added residues (i.e., Trp695) to allow NADPH
binding and flavin reduction.
The structure of the isolated NADP-binding lobe of human
NOX2 is available (PDB ID code 3ALF). As expected, its overall
conformation is very similar to that of the same region of csDH.
It is of note, however, that there is a large outward shift in the
position of the C-terminal residues (up to 7.9 Å for Phe570 of
NOX2 compared with the homologous Phe693 of csDH) (Fig.
S1C). This conformational change might reflect the absence of
the FAD-binding domain in the human NOX2 partial structure.
Nevertheless, because the superposition of these two structures
does not display any structural clash, the shift of the C-terminal
Phe also indicates that in NOXs this residue can potentially
move inward and outward from the active site.
NOX DH Domain Contains Structural Features That Are Unique in the
Ferredoxin-NADP Oxidoreductase Superfamily. csDH was further
compared with ferrodoxin-NADPH reductases to outline key
structural features at the heart of enzyme regulation (Fig. 2 and
Fig. S1 B and E). A first characteristic element is a hairpin within
the FAD-binding lobe (Q489-G509). This segment is longer in hu-
man NOX5 than in the other NOX members and binds Hsp90,
which is involved in NOX5 stability and activity (17). The other
NOX5-specific elements pertain to calcium-regulation, namely
two extended segments known to be involved in EF-hand and
calmodulin-binding, respectively (18, 19). Upon increase of in-
tracellular Ca2+, the N-terminal EF-hand domain binds to and
activates NOX5. In the csDH structure, the EF-hand binding loop
is unstructured (D611-T634), probably because of a dynamic role and
associated conformational changes that may accompany the en-
zyme activation. Calmodulin further sensitizes human NOX5 to































Fig. 1. Characterization of the mutant csDH domain and its structure in
complex with FAD. (A) Thermal denaturation curves demonstrate higher
stability of the mutant csDH (solid line, Tm = 67 °C) compared with the WT
(dashed line, Tm = 48 °C). Data are representative of three independent
experiments. The fluorescence intensity (vertical axis) is plotted against the
temperature (horizontal axis). (B) Overall view of csDH with bound FAD
(carbons in yellow). The FAD-binding lobe is in orange and the NADPH-
binding lobe in gray. Residues of the C-terminal PW695LEL extension are in
black. (C) NADPH-oxidase activity of the isolated csDH. WT (●) exhibits kcat =
128.5 ± 9.0 min−1, Km = 58.6 ± 11.0 μM, whereas the C-terminally extended
mutant (■) shows kcat = 22.8 ± 3.9 min
−1 and Km = 165.3 ± 59.5 μM. In this
assay, dioxygen is used as the electron-accepting substrate that regenerates
the oxidized flavin. The reaction becomes fourfold faster using ferricyanide
as electron acceptor (kcat = 261.9 ± 27.7 min
−1 and Km = 84.54 ± 22.8 μM).
(D) The NADPH-binding cleft. NADPH (green carbons) is modeled with the
nicotinamide stacking against the isoalloxazine moiety of FAD (yellow car-
bons) by similarity with spinach ferredoxin-reductase (16). Oxygens are
in red, nitrogens in blue, and phosphorous in orange. Phe693, at the
C terminus, is in dark gray.
Fig. 2. Characteristic structural features of csDH. The domain is depicted in
orange with the calmodulin-binding region in blue (R644-V663) (see Fig. S1B),
the unstructured EF-hand binding loop in dotted gray (D611-T634), and the
protruding hairpin of the FAD-binding lobe in purple (Q489-G509).








Ca2+ by binding in a region, which, as now shown by the crystal
structure, is a solvent-exposed α-helical segment downstream the
EF-binding loop (R644-V663) (Fig. 2 and Fig. S1E). Although cal-
modulin is not found in prokaryotic cells, the conservation of the
calmodulin-binding region (37% identity between human and
C. stagnale) (Fig. S1B) may not be merely vestigial, as we cannot
exclude the existence of a Ca2+-binding protein with similar func-
tion to calmodulin in C. stagnale. In essence, DH can be described
in terms of a typical NADP-ferredoxin oxidoreductase scaffold
(16), which is enriched by specific regulatory elements and a mobile
C-terminal segment.
An Uncommon Oxygen-Reacting Center. The TM domain of csNOX5
(residues 209–412) was crystallized in a lipid mesophase, which
provides a better crystallization environment for membrane pro-
teins (20). Because no suitable homology model was available for
molecular replacement, we exploited the anomalous signal of the
iron atoms bound to the two b-type heme groups (13). The 2.0-Å
resolution crystal structure of csTM has an overall pyramidal
shape with a triangular base on the inner membrane side and a
narrower apex toward the outer membrane face (Table S1). The
domain encompasses six transmembrane helices (h1–h6) and an
additional N-terminal α-helix, which runs at the surface of and
parallel to the inner side of the membrane (Fig. 3 A–C). The
electron density shows the TM to be decorated by four lipid li-
gands that bind along the helices h1, h3, and h4, and a fifth lipid
wedged between the transmembrane helices h1, h2, and h3 (Fig.
S2). The two hemes of the transmembrane portion of NOX are
positioned with their planes orthogonal to the lipid bilayer in a
cavity formed by helices h2, h3, h4, and h5 (Fig. 3C). The line
connecting their iron atoms is almost exactly perpendicular to the
plane of the bilayer (Fig. 3 A and B). In this way, one heme lies
proximal to the cytosolic (inner) side of the domain, whereas the
second heme is located toward the outer extracytoplasmic side.
The two porphyrins are both hexa-coordinated because they are
ligated via two pairs of histidines belonging to helices h3 and h5
(Fig. 3 D and E). Reduction with dithionite leads to a red shift of
the Soret γ-band from 414 nm to 427 nm, accompanied by an
increase of amplitude of the α- (558 nm) and β- (528 nm) bands,
which is characteristic of heme hexa-coordination (Fig. 4A).
Consistently, we could not detect any inhibition by cyanide even at
high concentrations, as expected for hexa-coordinated hemes (Fig.
4B) (21, 22).
We analyzed the csTM structure to model a plausible route for
electron passage across the two hemes. The metal-to-metal dis-
tance is 19.8 Å, whereas the shortest interatomic distance (6.4 Å)
is between vinyl 2 of the inner heme and vinyl 4 of the outer
heme (Fischer nomenclature). A cluster of hydrophobic residues
(Met306, Phe348, Trp378) intercalates between the two pros-
thetic groups; of those, the Trp378 indole is within Van der
Waals contact distance from both porphyrins (Fig. 5 A and B).
Based on these observations, we hypothesize that a favorite route
for electron transfer can be from vinyl 2 of the inner heme via
Trp378 to vinyl 4 of the outer heme. The electron is then finally
transferred to a dioxygen molecule. In this regard, inspection of




































Fig. 3. TM of NOX consists of six transmembrane helices and contains two heme groups positioned almost orthogonally to the lipid bilayer. (A–C) Overall
structure of csTM depicted in different orientations (outer, side, and cytosolic view). Transmembrane helices are labeled sequentially as h1–h6. (D and E)
Crystallographic data outline the hexa-coordinated nature of the outer and inner heme groups, respectively. The weighted 2Fo–Fc electron density maps are
contoured at 1.4 σ levels.
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located above the outer heme and occupied by a highly ordered
water molecule (Fig. 5C). This cavity is lined by the propionate
7 of the heme (Fisher nomenclature) and the strictly conserved
residues Arg256, His317, and iron-coordinating His313. Many
features indicate that the cavity-bound water molecule actually
occupies the position of the dioxygen substrate. Its H-bonding
environment is clearly suited for O2 binding and sequestration (Fig.
5D). Moreover, the positive charge of Arg256 can electrostati-
cally promote the catalytic production of superoxide, as observed in
other oxygen-reacting enzymes (23, 24). In agreement with the
notion that the site lined by Arg256 and His317 is involved in O2
binding and catalysis, we found that reoxidation of chemically
reduced csTM is greatly impaired by mutations targeting these two
residues (Fig. 5 C and D). Rapid kinetics experiments show that





































Fig. 4. UV/visible absorption spectra of native and reduced csTM domain support the hexa-coordinated nature of heme binding to NOX5. (A) Spectra of
purified csTM alone (anaerobiosis; black) reduced with dithionite (blue) and reoxidized with dioxygen (purple). (B) csTM does not react with cyanide. Spectra
of purified csTM incubated first with 1 mM potassium cyanide (green), then with 10 mM dithionite (blue), and reoxidized with dioxygen (purple). Insets show
expanded spectra in the range between 500 and 700 nm.
Fig. 5. A model for the TM–DH core of NOX catalytic subunit as gathered from the crystal structures of DH and TM domains from csNOX5. (A) The in silico
docking of csTM (light blue) and csDH (orange) structures is shown in a putative active conformation (see Fig. S4 and SI Materials and Methods for details).
(B) A distance of 19.8 Å separates the metal centers of the two heme groups of TM. Electron transfer may follow a path through Trp378. This residue
corresponds to a Val362 in human NOX5 (but the adjacent Trp363 may also offer a suitable route), Phe215 in human NOX2, and Phe200 in human NOX4 (Fig.
S1B and Table S5). (C) A highly ordered water molecule is present in a cavity lined by the outer heme at 3.8 Å distance from the iron (Fig. 3 A–C) and exposed
toward the external milieu, highlighting the oxygen-reacting center. The weighted 2Fo–Fc electron density map is contoured at 1.4 σ level. (D) Schematic view
of the cavity with groups putatively interacting with dioxygen.








reduced WT csTM is very quickly oxidized even at low O2 con-
centration (∼300 s−1 at 4.5 μM O2). Conversely, the R256S and
H317R mutants can be fully reoxidized only at higher O2 con-
centration (600 μM), with rates at least fivefold lower than ob-
served for WT csTM (Fig. S3 and Table S3). Notably, whereas the
R256S mutant displayed the same apparent melting temperature
(Tm) as the WT (61 °C), the H317R variant showed lower protein
stability (appTm = 43.5 °C) (Table S4). The functional importance
of Arg256 and His317 is further documented by disease-inducing
mutations affecting the corresponding residues of human NOX2.
These mutations were shown to impair catalytic activity (25–27),
but until now no mechanistic explanation could be provided (for
an extended analysis of NOX2 mutations, see Fig. S4A and
Table S5).
These findings have far-reaching implications for our un-
derstanding of the chemical mechanism of ROS generation.
Dioxygen binding does not appear to occur through direct co-
ordination to the iron of the heme, which is in a hexa-coordinated
state (Fig. 5C). Rather, dioxygen interacts noncovalently with the
prosthetic group and surrounding hydrophilic side chains. This
observation implies that superoxide formation does not happen
through an innersphere mechanism, which is brought about by
the oxygen directly coordinating to the iron as, for example, in
the globin class of hemoproteins (28). It is instead an outer-
sphere reaction that affords reduction of molecular oxygen
through an electron transfer step, as originally suggested by
Isogai et al. (29). This may occur either by direct contact be-
tween the reduced heme and O2 or be mediated by the iron-
coordinating His313 side chain.
A Structural Framework for NOX Catalysis and Regulation. With the
insight gained from the individual DH and TM domains, we next
addressed the issue of their assembly to model the NOX catalytic
core. A first noteworthy observation is that the surface on the
inner side of TM is remarkably complementary in shape to the
bilobal surface of DH, where the flavin ring is exposed (Fig. 5 A
and B and Fig. S4 B and C). Furthermore, the C terminus of the
csTM structure (residue 412) must necessarily be close in space
to the N terminus of csDH (residue 413). On these bases, the two
domain structures were computationally docked to generate a
full TM–DH complex (see SI Materials and Methods for details).
This model corresponds to the epsilon splicing isoform of human
NOX5, which lacks the regulatory N-terminal EF-hand domain
(30). Of relevance, the catalytic subunits of the oligomeric
NOX1–4 also consist only of DH–TM with no other domains
(14). Therefore, the general functional and catalytic implications
of our analysis are likely to be relevant to the whole NOX family.
A first point outlined by the TM–DH model is that the flavin is
positioned with its exposed dimethylbenzene ring in direct contact
with the TM’s inner heme (the propionate chains in particular)
(Fig. 5B). This geometry is obviously suited to promote the inter-
domain electron transfer that injects the NADPH-donated elec-
trons from the flavin to the heme-Trp378-heme array. Another
critical observation concerns the extensive interdomain interac-
tions involving the C-terminal residues of DH and the loops con-
necting helices h2–h3 and h4–h5 of TM (known as B and D loops,
respectively) (Fig. 3C and Fig. S1B). In NOX4 and NOX2, these
loops were shown to contribute to the regulation of the enzyme
activity (31, 32). Of note, our structural model positions the TM’s
B-loop in direct interaction with a highly conserved α-helix/
β-strand element of DH (Fig. S5). These residues (L507-L533) are
part of the B-loop interacting region as reported for NOX2 and -4
based on peptide-binding experiments (Fig. S1B) (31). More-
over, Arg360 and Lys361 on loop D are modeled in direct con-
tact with the C-terminal Phe693 of DH, in the core of the
nicotinamide-binding site (Fig. S4 B and C). This arrangement is
fully consistent with published data demonstrating that both loops
contribute to the ROS-producing activity and its regulation in
NOX2/4 (31, 32).
The elucidation of NOX 3D structure outlines a general scheme
for NOX regulation with the C-terminal residues functioning as
regulatory toggle switch. A mobile C-terminal segment is hinted by
the above-discussed structural comparisons between the NADPH-
binding lobes of csDH and human NOX2 (Fig. S1C). Notably, an
aromatic C-terminal residue (i.e., Phe693 in csNOX5) is wide-
spread among NADP-ferredoxin reductases, where it is often
found to change its conformation depending on NADPH-binding
(16). The substitution Phe693Ser showed a twofold increase in
Vmax compared with the WT, whereas the deletion of Phe693 did
not elicit any remarkable change on the steady-state kinetic
properties of the DH domain (Table S2). This observation implies
that Phe693 has a limited influence on the catalysis of the isolated
DH domain, which is in a deregulated active state. Rather, the
regulatory role of strictly conserved Phe693 is predicted to emerge
only in the context of the full-length protein. Phe693 and nearby
C-terminal residues may function as a receiver that conforma-
tionally transduces inhibitory or activating signals from other
regulatory domains or subunits. For example, in the case of
NOX5, the regulatory calmodulin- and EF-hand binding segments
are located in proximity of the C-terminal residues and NADPH-
binding site (Fig. 2). It can be envisioned that Ca2+-dependent
activation may entail the binding of EF-hand and calmodulin to
their respective receiving loops, thereby promoting the NADPH-
binding conformation of the nearby residues (Fig. S6). It can also
be hypothesized that these conformational changes further pro-
mote the attainment of the competent redox-transfer conforma-
tion at the flavin–heme interface where the D-loop is located (Fig.
S6). Given the high conservation of the C-terminal residues,
similar mechanisms to convey regulatory signals to the catalytic
core might be operational also in other NOXs (33, 34) (Fig. S1B).
Of interest, an allosteric mechanism of enzyme regulation in-
volving NADH-binding has been recently found also in the fla-
voenzyme apoptosis-inducing factor (35). The crucial feature of
this mechanistic proposal is that NADPH-oxidation at the flavin
site takes place only when the enzyme is in the active conforma-
tion, thus preventing the risk of NADPH-derived electrons being
diverted to nonproductive redox reactions.
The powerful production (or its deregulation/deficiency) of
ROS by NOXs underlies pathological conditions, such as oxi-
dative stress, malignancies, neurodegenerative disease, senes-
cence, and chronic granulomatous disease (1–12) (Fig. S4A and
Table S5). Our results highlight key structural elements common
to the entire NOX family, such as the toggle-switch at the C
terminus and the dioxygen binding pocket. The NOX structural
model presented here and its analysis bear strong implications
for the design of drugs targeting the NOX family.
Materials and Methods
Protein expression, purification, mutant preparation, and enzymatic assays
are described in SI Materials andMethods. Initial crystallization experiments on
the csDH and csDH-PWLELAAA were carried out at 20 °C using Oryx8 robot
(Douglas Instruments) and sitting-drop vapor-diffusion technique. The drops
were composed of 0.2 μL of 7 mg/mL protein in 50 mM Tris·HCl pH 7.5, 5%
(vol/vol) glycerol, and 0.2 μL of reservoir from commercial screens (JCGS core
suite I, II, III, and IV from Qiagen). Crystals of csDH-PWLELAAA grew overnight
in two different conditions: (i) 160 mM Ca-acetate, 80 mM Na-Cacodylate
pH 6.5, 14% (wt/vol) PEG 8000, 20% (vol/vol) glycerol; and (ii) 100 mM CHES
pH 9.5, 40% (vol/vol) PEG 600. Crystals used for data collection were obtained
using a reservoir consisting of 160 mM Ca-acetate, 80 mM Na-Cacodylate pH
6.5, 12–16% (wt/vol) PEG 8000, 20% (vol/vol) glycerol. csTM was concentrated
to 25 mg/mL and mixed with monoolein (1-oleoyl-rac-glycerol) in a 2:3 protein
to lipid ratio (wt/wt) using two coupled syringes (Hamilton) at 20 °C. The in
meso mix was dispensed manually using a Hamilton syringe coupled to a re-
petitive dispenser onto a sandwich plate in a 120-nL bolus overlaid by 1 μL of
precipitant solution. Red csTM crystals grew in 2 d at 20 °C in 30% (vol/vol)
PEG300, 100 mM Li2SO4, 100 mM Mes-KOH pH 6.5.
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csDH crystals were harvested and flash-frozen in liquid nitrogen. Data were
measuredat 100Katbeam-lines in the Swiss Light Source (Villigen, Switzerland)
and European Synchrotron Radiation Facility (Grenoble, France). Data were
indexed and integrated with XDS (36) and scaled with aimless (CCP4suite) (37).
The structure of csDH was solved by molecular replacement using Balbes (37).
Initial amino acid placement was carried out using phenix.autobuild (38) and
checked by Coot. Refinement at 2.0 Å was done by iterative cycles of Refmac5
(37) and Coot (39). Datasets for the csTM were collected at European Syn-
chrotron Radiation Facility (Grenoble, France), Swiss Light Source (Villigen,
Switzerland), and Deutsches Elektronen-Synchrotron (Hamburg, Germany).
They were processed with XDS (36) and scaled with aimless (37). The initial
phases were obtained by iron-based single-wavelength anomalous dispersion
using the program autoSHARP (40). Two iron sites were identified and a crude
helical model was built by phenix.autobuild. Phases were recalculated on the
native dataset using DMMULTI (41). The model was further improved with
iterative cycles of coot, phenix.fem and Refmac5 (38, 39). Images were
prepared using Chimera (42) and CCP4MG (37). Electron flow trajectory was
calculated with VMD Pathways1.1 plug-in (43).
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